| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10032167 | American Journal of Obstetrics and Gynecology | 2005 | 9 Pages |
Abstract
For the treatment of PMDD, luteal phase dosing with 12.5 mg and 25 mg of paroxetine CR is effective and generally well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Meir MD, PhD, Angelica Lindén MD, PhD, Richard MD, PhD, Fiona MSc, Michelle D. PhD, Elisabeth MD,